304 results on '"Davidson, Brian R."'
Search Results
2. Techniques of biliary reconstruction for liver transplantation
3. Intra-peritoneal saline instillation versus no instillation for laparoscopic cholecystectomy
4. Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis
5. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis
6. Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis
7. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis
8. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis
9. Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis
10. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis
11. Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis
12. Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta-analysis
13. Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis
14. Pharmacological interventions for acute hepatitis C infection
15. Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis
16. Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis
17. Pharmacological interventions for acute pancreatitis
18. Imaging modalities for characterising focal pancreatic lesions
19. Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection
20. Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis
21. Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease)
22. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD)
23. Pharmacological interventions for primary sclerosing cholangitis
24. Pharmacological interventions for primary biliary cholangitis
25. Management of people with early- or very early-stage hepatocellular carcinoma
26. Pharmacological interventions for acute hepatitis B infection
27. Pharmacological interventions for acute hepatitis C infection
28. Management of people with intermediate-stage hepatocellular carcinoma
29. Interventions for hereditary haemochromatosis
30. Methods to decrease blood loss during liver resection: a network meta-analysis
31. Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer
32. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer
33. Interventions for necrotising pancreatitis
34. Management strategies for pancreatic pseudocysts
35. Laparoscopic versus open distal pancreatectomy for pancreatic cancer
36. Non-invasive diagnostic tests for Helicobacter pylori infection
37. Duodenum-preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitis
38. Pregabalin for decreasing pancreatic pain in chronic pancreatitis
39. Enhanced recovery protocols for major upper gastrointestinal, liver and pancreatic surgery
40. Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis and serum C-reactive protein, procalcitonin and lactate dehydrogenase for the diagnosis of pancreatic necrosis
41. Pancreatic amylase in drain fluid for the diagnosis of pancreatic leak in post pancreatic resection
42. Early versus delayed dressing removal after primary closure of clean and clean-contaminated surgical wounds
43. Early versus delayed post-operative bathing or showering to prevent wound complications
44. Immunosuppressive regimens for liver transplantation: a network meta-analysis
45. Treatments for hereditary haemochromatosis: a network meta-analysis
46. Pharmacological treatments for chronic hepatitis B liver disease: a network meta-analysis
47. Pharmacological treatments for chronic hepatitis C liver disease: a network meta-analysis
48. Pharmacological treatments for non-alcohol related fatty liver disease (NAFLD): a network meta-analysis
49. Management of people with intermediate-stage hepatocellular carcinoma: a network meta-analysis
50. Pharmacological treatments for acute hepatitis C infection: a network meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.